Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The new method can create hair follicle-like structures but not complete hair with roots and shafts, needing more improvement.

A new method using Platelet-rich Plasma (PRP) in a microneedle can promote hair regrowth more efficiently and is painless, minimally invasive, and affordable.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Baricitinib shows promise for treating alopecia areata with mild side effects.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Patients and doctors often disagree on alopecia areata severity and treatment satisfaction.

Alopecia areata is linked to autoimmune antibodies.

Overexpression of IKZF1 and Ikaros causes hair loss in mice similar to alopecia areata.

JAK inhibitors are effective for long-term management of alopecia areata.

A Japanese patient with a rare genetic disorder had a less severe case than others, suggesting other factors may affect symptoms.

New research is helping develop better treatments for alopecia areata.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

AGA patients have a lower quality of life than AA patients.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

A woman's hair grew back after treatment for a rare hair loss caused by proton therapy.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

The Turkish version of the Alopecia Areata Quality of Life Index is reliable and valid.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Poor air quality increases the risk of atopic dermatitis in Taiwan.

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Upadacitinib effectively treats severe alopecia areata and is safe.

Alopecia Areata is often linked to other health issues like allergies, thyroid problems, and diabetes.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

New and known mutations in the hairless gene cause a hair loss condition called Atrichia with papular lesions.

Baricitinib is an effective treatment for severe alopecia areata.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Environmental factors can trigger alopecia areata in identical twins.